← Back to all signals
RESEARCH PAPER ANALYSIS

[Surgical designs and clinical effects of pedicled transfer of extended lower trapezius musculocutaneous flap in repairing massive wounds in the shoulder and back].

AI interpretation is pending for this paper.

Open original publication →
PMID42706049
JournalZhonghua shao shang yu chuang mian xiu fu za zhi
Publication Date2026-08-20
Ingested2026-09-09 09:15 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

Objective: To explore the surgical designs and clinical effects of pedicled transfer of extended lower trapezius musculocutaneous flap (e-LTMF) in repairing massive wounds in the shoulder and back. Methods: This study was a retrospective case series study. From January 2009 to April 2023, 41 patients with massive wounds in the shoulder and back who met the inclusion criteria were admitted to Plastic Surgery Hospital of Chinese Academy of Medical Sciences and Peking Union Medical College, including 26 males and 15 females, aged 4 to 83 years. The surgical design was selected according to the nature of the wound and surgical timing. The 15 patients repaired with the conventional e-LTMF were included in conventional group, the 15 patients repaired with the modified e-LTMF incorporating a distal segment of the latissimus dorsi muscle were included in modified group, and the 11 patients repaired with the pre-expanded e-LTMF were included in pre-expanded group. The wound areas ranged from 7 cm×5 cm to 21 cm×12 cm and the harvested musculocutaneous flap areas ranged from 7 cm×5 cm to 33 cm×10 cm in patients in conventional group. The wound areas ranged from 16 cm×8 cm to 28 cm×18 cm and the harvested musculocutaneous flap areas ranged from 25 cm×8 cm to 40 cm×12 cm in patients in modified group. The wound areas ranged from 12 cm×8 cm to 36 cm×12 cm and the harvested musculocutaneous flap areas ranged from 22 cm×8 cm to 35 cm×15 cm in patients in pre-expanded group. The musculocutaneous flaps were transferred to the recipient sites in a fashion of propeller rotation or as an island flap through a subcutaneous tunnel. The donor site wounds were repaired by direct suture, local flap transfer, or skin grafting. After surgery, the survival of musculocutaneous flaps was observed, the complete survival rate and the necrosis rate of musculocutaneous flaps were calculated, and the management and outcome of the necrotic musculocutaneous flaps were recorded. During follow-up, the appearance and texture of the musculocutaneous flaps, the recovery of the affected upper limb and the shoulder and back at recipient sites, the tumor recurrence in patients with tumors, and the wound healing at donor sites were observed. Results: After surgery, among the 41 patients, the musculocutaneous flaps survived completely in 38 patients, with a complete survival rate of musculocutaneous flaps of 92.7% (with a 95% CI of 80.6% to 97.5%). The necrosis of the musculocutaneous flaps occurred in 3 patients, with a necrosis rate of musculocutaneous flaps of 7.3% (with a 95% CI of 2.5% to 19.4%). Among them, total necrosis of the musculocutaneous flaps occurred in one patient in conventional group, whose wound healed after skin grafting. Distal necrosis of the musculocutaneous flap occurred in two patients in modified group, whose wounds both healed after dressing changes. During the follow-up of 1 to 48 months after surgery, the color and texture of the musculocutaneous flaps were similar to those of the normal skin surrounding the recipient sites, no obvious limitation was observed in the motion of the affected upper limb or the shoulder and back at recipient sites, and no tumor recurrence was observed in patients with tumors. The wounds at donor sites all healed well. Conclusions: Three surgical designs of e-LTMF can be used to repair massive wounds of varying complexity in the shoulder and back, achieving good outcomes in postoperative musculocutaneous flap survival, appearance and texture, recovery of the affected upper limb and the shoulder and back at recipient sites, and donor site wound healing. Among them, the conventional e-LTMF can be used for repairing simple skin and soft tissue defects, the modified e-LTMF incorporating a distal segment of the latissimus dorsi muscle can be used for repairing complex wounds complicated by exposure of critical structures, wound infection, or dead-space formation, and the pre-expanded e-LTMF can be used for elective reconstruction of wounds requiring larger musculocutaneous flap coverage.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 [Evaluation of the Educational Effects of Cervical Cancer and HPV Vaccine Education for Junior High School Students]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 41.7 2 The National Couples' Health and Time Stress Biology Study (NCHAT-BIO): Wave 1 Methodology Report and Wave 3 Preview. Biopsychosocial science and medicine 65.7 3 Communication quality shapes the sustainability of pediatric early warning system. BMC health services research 63.4 4 Treatment of children with Kawasaki disease complicated by selective IgA deficiency using immunoglobulin preparations: a case report. BMC pediatrics 56.24 5 Hotspot mutations and tumour spectrum in von Hippel-Lindau syndrome: genotype-phenotype analysis of a large Chinese cohort. Journal of cancer research and clinical oncology 64.7 6 Perioperative outcomes and appendiceal malignancy in elderly patients with acute appendicitis: a comparative retrospective cohort study. Langenbeck's archives of surgery 68.0 7 Posttransplant lymphoproliferative disorders following hematopoietic stem cell transplantation: a clinicopathological study of a large single-center cohort. Annals of hematology 66.7 8 Therapeutic NAMPT inhibition reveals a targetable metabolic vulnerability in neuroblastoma. Journal of experimental & clinical cancer research : CR 60.04 9 Comparison of thyroglossal duct cysts in adults and children: 11 years of clinical experience. Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 67.8 10 Adult Pott's Puffy Tumor in the ED. Cureus 49.9 11 Long-term remission after surgical excision and minimal rituximab exposure in localized high-grade B-cell lymphoma with 11q aberration. Journal of clinical and experimental hematopathology : JCEH 62.56 12 Sixteen-year changes in hazardous metal(loid)s in urban topsoils: Land-use-specific enrichment and PM₁₀-based human health risk. Journal of hazardous materials 58.7 13 Mesenchymal Malignant Transformation in Metanephric Stromal Tumor: Expanding the Pathologic Spectrum of Metanephric Neoplasia. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 55.0 14 Intramuscular Myxoma of the Shoulder in Neurofibromatosis Type 1. Cancer diagnosis & prognosis 49.9 15 Hepatic Tumoral Calcinosis in a Patient With Obesity and Metabolic Syndrome: A Case Report. Case reports in surgery 47.5 16 A Large Multicenter Cohort of Ataxia-Telangiectasia: Clinical, Immunologic, Genetic, and Survival Outcomes. European journal of neurology 68.62 17 Effects of insulin resistance on pregnancy outcomes and complications in women with polycystic ovary syndrome. The Journal of international medical research 67.0 18 Genetic testing considerations for hereditary duodenopancreatic neuroendocrine tumors. Journal of neuroendocrinology 62.5 19 Clinical Features, Treatments, and Outcomes of an International Cohort of 96 Children with Takayasu Arteritis. ACR open rheumatology 67.74 20 It's a Trap! CDK8 Inhibition Reveals a Shared Vulnerability through Mediator Trapping in Fusion-Driven Pediatric Sarcomas. Cancer discovery 56.5 21 Recruitment, Retention, and Patient Engagement of Adolescents and Young Adult Cancer Survivors in Psycho-Oncology Research: A Qualitative Study. Journal of adolescent and young adult oncology 56.0 22 The Role of Genetic Profiling in Pediatric Brain Tumors. Balkan medical journal 47.5 23 Voices in Molecular Pharmaceutics: Meet Dr. Ritika Gupta Who Seeks to Light up Pediatric Tumors with Targeted Fluorescence Imaging Agents. Molecular pharmaceutics 47.5 24 Patterns of Pediatric Cancer Care at a Tertiary Center in Pakistan: A Hospital-Based Registry Analysis. Pediatric blood & cancer 66.9 25 Natural Killer Cell-Based Immunotherapy in Retinoblastoma: Biological Basis, Preclinical Evidence, and Translational Challenges. Pediatric blood & cancer 66.5 26 Perioperative Management of Children, Adolescents and Young Adults Undergoing Surgical Treatment for Oncologic Thoracic Disease: Retrospective Single-Center Analysis. Pediatric blood & cancer 67.14 27 A Clot Before the Cancer: Cerebral Venous Sinus Thrombosis as the Initial Presentation of Childhood Acute Leukemia-A Case Report and Literature Review. Pediatric blood & cancer 39.0 28 Creation of a Tailored Social Media Campaign to Educate Adolescents and Young Adults About Clinical Trials: The Talk to Me Study. Journal of adolescent and young adult oncology 72.2 29 Re: Robot-assisted minimally invasive surgery in paediatric neuroblastoma: does the actual technology truly expand selection criteria? Pediatric surgery international 47.5 30 Enablers and barriers to human papillomavirus vaccination implementation among key stakeholders in Ethiopia: A qualitative study. PloS one 62.5 31 Cohort Profile: The Adolescent and Young Adult Tracking Engagement and Management Skills (AYA TEAMS) longitudinal cohort of childhood cancer survivors in the United States. PloS one 67.4 32 Identifying novel genomic alterations in relapsed childhood B-ALL: a report from the Children's Oncology Group. Blood 84.42
PATIENT-FRIENDLY SUMMARY

[Surgical designs and clinical effects of pedicled transfer of extended lower trapezius musculocutaneous flap in repairing massive wounds in the shoulder and back].

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic